Falcon Point Capital’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAT
ACH
CS
SIMG
RCAMU
Falcon Point Capital's BEAT Position: Q3 2019 in Review
Falcon Point Capital sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 49,987 shares — an estimated $2.41M sold.
Falcon Point Capital first reported a position in BEAT in Q4 2015 and held it in 15 quarters. The position peaked at $12.7M in Q3 2018. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.
- Falcon Point Capital reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
- Falcon Point Capital sold 49,987 BioTelemetry, Inc. shares in Q3 2019, an estimated $2.41M.
- Falcon Point Capital first reported a position in BioTelemetry, Inc. in Q4 2015 and held it in 15 quarters.
- Falcon Point Capital's BioTelemetry, Inc. position peaked at $12.7M in Q3 2018.
- 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.
Based on Falcon Point Capital's 13F filing for Q3 2019, filed 13 Nov 2019.